David N Gill's Net Worth

$6.05 Million

Estimate Recalculated Jun 12, 2025 08:30PM EST

Who is David N Gill

David N Gill has an estimated net worth of $6.05 Million. This is based on reported shares across multiple companies, which include ISOTIS INC, CTI MOLECULAR IMAGING INC, CEMPRA, INC., Y-mAbs Therapeutics, Inc., HISTOGENICS CORP, LEMAITRE VASCULAR INC, Evolus, Inc., Strongbridge Biopharma plc, STRATA Skin Sciences, Inc., ECPM Holdings, LLC, NxStage Medical, Inc., and IDLEAIRE TECHNOLOGIES CORP.

SEC CIK

David N Gill's CIK is 0001106519

Past Insider Trading and Trends

2018 was David N Gill's most active year for acquiring shares with 8 total transactions. David N Gill's most active month to acquire stocks was the month of May. 2004 was David N Gill's most active year for disposing of shares, totalling 8 transactions. David N Gill's most active month to dispose stocks was the month of April. 2004 saw David N Gill paying a total of $109,218.75 for 147,300 shares, this is the most they've acquired in one year. In 2005 David N Gill cashed out on 345,247 shares for a total of $1,906,500.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ISOTIS INC

Investor
Updated Oct 30, 2007
Form 4
-100.00%
-5.00K
$6.00
-$30.00K
Oct 30, 2007
Disposition
Oct 29
Form 3
Jan 26, 2007
Showing 2 results

CTI MOLECULAR IMAGING INC

Senior Vice President and CFO
Updated May 06, 2005
Form 4
-100.00%
-341.95K
$20.50
-$2.04M
May 06, 2005
Disposition
Apr 29 - May 05
Form 4
$4.69
$45.47K
Jan 19, 2005
271.20K
Options
Jan 18
Form 4
$4.69
$49.22K
Oct 19, 2004
271.20K
Options
Oct 18
Form 4
$4.69
$60.00K
Oct 18, 2004
271.20K
Options
Oct 14
Form 4
18.75%
60.00K
Oct 12, 2004
386.40K
Acquisition
Oct 07
Form 4
-100.00%
-15.00K
$13.72
-$205.80K
Jun 04, 2004
6.40K
Sale
Jun 02
Form 4
-40.00%
-10.00K
$14.07
-$140.70K
May 13, 2004
21.40K
Sale
May 11
Form 4
-35.90%
-14.00K
$16.49
-$230.89K
Mar 03, 2004
31.40K
Sale
Mar 02
Form 4
-29.09%
-16.00K
$17.67
-$282.72K
Feb 19, 2004
45.40K
Sale
Feb 17
Form 4
19.55K
Feb 12, 2004
19.55K
Grant
Nov 25
Form 4
-8.33%
-5.00K
$15.45
-$77.25K
Dec 17, 2003
61.40K
Sale
Dec 15
Form 4
-24.09%
-19.04K
$15.38
-$292.76K
Dec 12, 2003
66.40K
Sale
Dec 10 - Dec 11
Showing 12 results

MELINTA THERAPEUTICS, INC. /NEW/

Investor
Updated Jun 12, 2019
Form 4
30.00K
Jun 12, 2019
30.00K
Grant
Jun 11
Form 4
34.10K
Jun 14, 2018
34.10K
Grant
Jun 12
Form 4
500.00%
5.00K
$6.09
$30.45K
May 30, 2018
6.00K
Purchase
May 25
Form 4
15.00K
Jan 05, 2017
105.00K
Grant
Jan 03
Form 4
5.00K
$2.94
$14.72K
Jan 04, 2017
90.00K
Purchase
Jan 03
Form 4
15.00K
Jan 05, 2016
85.00K
Grant
Jan 01
Form 4
15.00K
Jan 02, 2015
70.00K
Grant
Jan 01
Form 4
15.00K
Jan 10, 2014
55.00K
Grant
Jan 08
Form 4
15.00K
Feb 06, 2013
40.00K
Grant
Feb 04
Form 4
25.00K
Apr 04, 2012
25.00K
Grant
Apr 02
Form 3
Apr 04, 2012
Showing 11 results

Y-mAbs Therapeutics, Inc.

Investor
Updated Jun 13, 2024
Form 4
774.25%
18.04K
Jun 13, 2024
20.37K
Grant
Jun 11
Form 4
16.28K
Jun 09, 2023
16.28K
Grant
Jun 08
Form 4
16.00K
Jul 19, 2022
16.00K
Grant
Jul 15
Form 4
16.00K
Jun 14, 2021
16.00K
Grant
Jun 10
Form 4
-7.69%
-2.00K
$28.84
-$70.73K
Jan 20, 2021
24.00K
Sale
ScheduledJan 19
Form 4
-7.14%
-2.00K
$28.47
-$69.21K
Nov 20, 2020
26.00K
Sale
ScheduledNov 18
Form 4
-12.50%
-4.00K
$28.08
-$135.36K
Nov 05, 2020
28.00K
Sale
ScheduledNov 03
Form 4
16.00K
Jun 24, 2020
16.00K
Grant
Jun 23
Form 4
16.00K
Jun 14, 2019
16.00K
Grant
Jun 12
Form 3
Sep 20, 2018
Showing 10 results

HISTOGENICS CORP

Investor
Updated Jun 19, 2018
Form 4
25.00K
Jun 19, 2018
25.00K
Grant
Jun 15
Form 4
27.27%
3.00K
$1.81
$5.44K
Aug 17, 2017
14.00K
Purchase
Aug 16
Form 4
25.00K
Jun 14, 2017
25.00K
Grant
Jun 13
Form 4
37.50%
3.00K
$1.68
$5.04K
May 17, 2017
11.00K
Purchase
May 16
Form 4
10.00K
Dec 19, 2016
10.00K
Grant
Dec 16
Form 4
60.00%
3.00K
$1.65
$4.95K
Dec 15, 2016
8.00K
Purchase
Dec 15
Form 4
5.00K
$1.92
$9.60K
Dec 15, 2016
5.00K
Purchase
Dec 09
Form 4
6.80K
Jun 26, 2015
6.80K
Grant
Jun 24
Form 4
13.20K
Feb 02, 2015
13.20K
Grant
Feb 02
Form 3
Feb 02, 2015
Showing 10 results

LEMAITRE VASCULAR INC

Investor
Updated Jul 20, 2007
Form 4
7.50K
$6.10
$45.75K
Jul 20, 2007
7.50K
Grant
Jul 18
Form 4
17.23%
1.00K
$6.05
$6.05K
May 16, 2007
6.81K
Purchase
May 15 - May 16
Form 4
20.81%
1.00K
$6.25
$6.25K
May 10, 2007
5.81K
Purchase
May 09
Form 4
140.25%
2.81K
Dec 22, 2006
4.81K
Grant
Dec 22
Form 4
2.00K
$6.05
$12.10K
Nov 01, 2006
2.00K
Purchase
Oct 31
Form 3
Oct 18, 2006
Showing 6 results

Evolus, Inc.

Investor
Updated May 15, 2024
Form 4
-23.38%
-10.36K
$12.64
-$131.01K
May 15, 2024
33.96K
Sale
May 13 - May 14
Form 4
41.84%
15.84K
Feb 09, 2024
53.70K
Grant
Feb 07
Form 4
67.92%
20.08K
Jan 31, 2023
49.65K
Grant
Jan 27
Form 4
-25.86%
-10.31K
$13.35
-$137.66K
May 17, 2022
29.57K
Sale
May 13 - May 16
Form 4
157.51%
38.30K
Jan 26, 2022
62.61K
Grant
Jan 24
Form 4
386.26%
19.31K
Feb 09, 2021
24.31K
Grant
Feb 05
Form 4
23.46K
Jan 24, 2020
23.46K
Grant
Jan 23
Form 4
66.67%
2.00K
$13.65
$27.30K
Jun 14, 2019
5.00K
Purchase
Jun 13
Form 4
14.50K
Jan 25, 2019
14.50K
Grant
Jan 23
Form 4
3.00K
$12.77
$38.30K
Dec 17, 2018
3.00K
Purchase
Dec 14
Form 4
22.70K
Apr 26, 2018
22.70K
Grant
Apr 24
Form 3
Feb 12, 2018
Showing 12 results

Strongbridge Biopharma plc

Investor
Updated Oct 06, 2021
Form 4
-100.00%
-78.06K
Oct 06, 2021
Disposition
Oct 05
Form 4
-18.54%
-17.76K
$2.06
-$36.59K
Oct 05, 2021
78.06K
Tax
Oct 01
Form 4
71.66%
40.00K
May 18, 2021
95.82K
Grant
May 18
Form 4
-25.47%
-19.07K
$2.35
-$44.83K
May 17, 2021
55.82K
Tax
May 14
Form 4
11.96%
8.00K
$2.13
$17.04K
Sep 28, 2020
74.90K
Purchase
Sep 24
Form 4
-25.67%
-23.10K
$3.61
-$83.41K
Sep 04, 2020
66.90K
Tax
Sep 03
Form 4
80.00%
40.00K
May 15, 2020
90.00K
Grant
May 14
Form 4
50.00K
Sep 04, 2019
50.00K
Grant
Sep 03
Form 3
Sep 04, 2019
Showing 9 results

STRATA Skin Sciences, Inc.

Investor
Updated Nov 26, 2019
Form 4
39.42%
18.29K
Nov 26, 2019
64.69K
Grant
Nov 22
Form 4/A
209.34%
31.40K
Jul 17, 2018
46.40K
Grant
Jun 08
Form 4
26.57K
Jun 11, 2018
26.57K
Grant
Jun 08
Form 3
May 30, 2018
15.00K
Showing 4 results

EndoChoice Holdings, Inc.

President and CFO
Updated Nov 23, 2016
Form 4
-100.00%
-250.09K
$8.00
-$1.31M
Nov 23, 2016
Disposition
Nov 22
Form 4
38.39%
47.06K
Mar 31, 2016
196.26K
Grant
Mar 29
Form 4
8.65%
2.00K
$4.70
$9.40K
Mar 10, 2016
149.20K
Purchase
Mar 10
Form 4
27.58%
5.00K
$4.77
$23.85K
Mar 07, 2016
147.20K
Purchase
Mar 07
Form 4
135.88%
107.65K
Aug 17, 2015
196.03K
Grant
Aug 14
Form 3
Jun 05, 2015
88.38K
Showing 6 results

NxStage Medical, Inc.

SVP & CFO
Updated Oct 27, 2005
Form 3
Oct 27, 2005
Showing 1 results

IDLEAIRE TECHNOLOGIES CORP

Investor
Updated Jul 03, 2006
Form 3
Jul 03, 2006
Showing 1 results